Orange Book product · Generic (ANDA)
STAVUDINE
STAVUDINE
At a glance
Dec 29, 2008
Approved
Generic (ANDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Dec 29, 2008
17 yr 9 mo ago
Today
Pharmaceutical detail
Active ingredient
STAVUDINE
Strength
1MG/ML
Dosage form
FOR SOLUTION
Route
ORAL
TE code
Not listed
Application
ANDA 077774
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of STAVUDINE
- 2002ZERIT XRBrand (NDA)
NDA 021453 · BRISTOL MYERS SQUIBB
- 1996ZERITBrand (NDA)
NDA 020413 · BRISTOL
- 1994ZERITBrand (NDA)
NDA 020412 · BRISTOL
- 2009STAVUDINEGeneric (ANDA)
ANDA 078030 · CIPLA LTD
- 2009STAVUDINEGeneric (ANDA)
ANDA 078775 · PHARMOBEDIENT
- 2008STAVUDINEGeneric (ANDA)
ANDA 077672 · AUROBINDO PHARMA
- 2008STAVUDINEGeneric (ANDA)
ANDA 078957 · HETERO LABS LTD III
- 2008STAVUDINEGeneric (ANDA)
ANDA 079069 · PHARMOBEDIENT
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
